Volume 40, Issue 2 (March 1995)

    Development of a Fluoroimmunoassay for the Detection of Buprenorphine in Urine

    (Received 26 July 1993; accepted 2 August 1994)

    CODEN: JFSOAD

      Format Pages Price  
    PDF 4 $25   ADD TO CART


    Abstract

    The development of a fluoroimmunoassay for the detection of buprenorphine in urine samples is described. Fluore-scein-norbuprenorphine and pseudobuprenorphine, the dimer of buprenorphine, were synthesized as tracer molecules. The antibodies were prepared by coupling the 2-diazobenzoic acid derivative of buprenorphine with bovine serum albumine, using the carbodiimide method. The assay was mainly used for the routine detection of buprenorphine in urine specimens of persons suspected of Temgesic® abuse. The minimum detectable dose of the immunoassay was calculated to be 20 ng/mL.


    Author Information:

    Debrabandere, L
    Research Associate, Senior Research Associate, and Professor of Toxicology, University of Leuven, Laboratory of Toxicology, Leuven,

    Van Boven, M
    Research Associate, Senior Research Associate, and Professor of Toxicology, University of Leuven, Laboratory of Toxicology, Leuven,

    Daenens, P
    Research Associate, Senior Research Associate, and Professor of Toxicology, University of Leuven, Laboratory of Toxicology, Leuven,


    Stock #: JFS15352J

    ISSN: 0022-1198

    DOI: 10.1520/JFS15352J

    ASTM International
    is a member of CrossRef.

    Author
    Title Development of a Fluoroimmunoassay for the Detection of Buprenorphine in Urine
    Symposium , 0000-00-00
    Committee E30